ERBB2 and cancer: Within 8 days, all the cancer cells transfected with ERBB2 3’UTR-destabilizing elements showed loss of viability and increased caspase 3/7 expression (Supplementary Figure S1K) compared to the wildtype cells and the vector control cells (Figure 2B).